AtomVie Global Radiopharma Inc.

Before we head into 2025, AtomVie Global Radiopharma (AtomVie) would like to take a moment and reflect upon some of the highlights we had throughout the year!   2024 marked an incredible year of achievements and it was a testament to the monumental dedication and expertise of our teams. This year has been a true reflection of our mission of transforming patients lives with high quality radiopharmaceuticals. Thanks to all the hard work and support from our partners and staff, we are proud to call this year a success. We appreciate everyone who has been part of our journey in 2024 and we are excited to carry this momentum forward. We hope everyone has a safe and joyful holiday season, and we look forward to even greater growth and accomplishments together in 2025!   Watch the full wrap-up video below to relive these 2024 moments with us.   #AtomVieGlobalRadiopharma #2024Highlights #HappyHolidays #Growth #LookingAhead2025

As we approach the end of 2024, AtomVie Global Radiopharma (AtomVie) is reflecting on the remarkable progress and expansion within the radiopharmaceutical industry. This year has been defined by significant investments, high-impact partnerships, notable acquisitions, and positive clinical trial outcomes—highlighting the transformative potential of radiopharmaceuticals in patient care.   AtomVie is proud to continue playing a vital role in advancing this dynamic industry as trusted CDMO partner to innovators worldwide. Our new 72,300-square-foot facility, designed to scale production to more than 10 times our current capacity is equipped to support the development of pipeline assets, clinical and commercial manufacturing for our partners. This growth underscores our commitment to working with industry leaders globally to deliver high-quality radiopharmaceuticals that transform patients’ lives.   We have shared selected highlights and key market trends in the slides below - check them out and let us know what you observed in 2024 and where you see the industry going in the comments below!   #AtomVieGlobalRadiopharma #2024MarketTrends #Radiopharmaceuticals #IndustryGrowth #TransformingLives

As we close out yet another successful year, the AtomVie Global Radiopharma (AtomVie) employees gathered for our end of year all-staff meeting to celebrate all the milestones and achievements that we made throughout the last quarter of 2024. From showcasing awards and recognitions, highlighting our outstanding teams, including an incredible spotlight section on Quality at AtomVie that left us speechless, to enjoying a delicious breakfast together, It was a wonderful and festive opportunity to have all our staff gathered before the holidays to recognize all the hard work and dedication that has propelled us forward in being a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). All of these moments of celebration and achievement serve as a reminder of our commitment to transforming patients' lives with high quality radiopharmaceuticals.   We are even more excited about what is on the horizon for 2025, with our upcoming state-of-the-art 72,300 sq ft manufacturing facility, which will be increasing our capacity by at least 10x our current volume. If you would like to learn more about our facility and our capabilities, you can visit our website https://lnkd.in/gD67dDfF and contact us.   Thank you to everyone who made this event a memorable one! Here's to the joy of the holiday season - Take a look at some of the highlights we captured throughout the sessions below!   #AtomVieGlobalRadiopharma #AllStaff #HappyHolidays #YearEndCelebration #Radiopharmaceuticals #LookingAhead2025

We're #hiring a new Shop Floor Quality Associate in Hamilton, Ontario. Apply today or share this post with your network.

Many thanks to Hamilton Economic Development and the dynamic City Of Hamilton community for inviting AtomVie Global Radiopharma (AtomVie) to the panel discussion with Centre for Probe Development and Commercialization (CPDC) and McMaster University , 'Transforming Healthcare: Radiopharmaceuticals Driving Breakthrough Innovations,' last week. We were thrilled to be part of this ONeconomy | ÉconomieON event , where we had the opportunity to connect with local leaders and innovators in the nuclear medicine field.   We are excited to be part of the growing nuclear medicine community in Hamilton, the Radiopharmaceutical hub in Ontario. The event was a powerful reminder of the transformative potential of radiopharmaceuticals in shaping the future of healthcare. At AtomVie, we are committed to transforming patients' lives with high-quality radiopharmaceuticals. Here’s to continued collaboration and innovation!   #AtomVieGlobalRadiopharma #Radiopharmaceuticals #PanelDiscussion #HealthInnovation #Collaboration  

AtomVie Global Radiopharma (AtomVie) is excited to welcome Dr. Pratibhash (Bosh) Chattopadhyay, to the AtomVie team as our Chief Business Officer. Bringing over 25 years of commercial and technical expertise in life sciences, Dr. Chattopadhyay brings invaluable leadership and experience to AtomVie, having successfully led commercialization initiatives in oncology and advanced drug delivery technologies. joins us at a pivotal moment as we near the completion of our state-of-the-art facility in 2025. This cutting-edge facility will increase our production by at least ten-fold the current capacity to meet the global demand for radiopharmaceuticals.   We encourage you to connect with Dr. Chattopadhyay to learn about our leadership and how our expertise can support your strategic objectives. Visit us on our website to learn more - https://lnkd.in/eTEt4jTu   For the full Press Release: https://lnkd.in/g9PMnnKS   #AtomVieGlobalRadiopharma #PressRelease #BusinessGrowth #ChiefBusinessOfficer #ConnectWithUs #Leadership

We're #hiring a new Accounts Payable Clerk (Contract) in Hamilton, Ontario. Apply today or share this post with your network.

We would like to extend our sincere thanks to Canadian Nuclear Isotope Council (CNIC) for inviting us to participate in the "Securing Isotope Investment" virtual event, in collaboration with Canadian Medical Isotope Ecosystem. As proud members of CNIC, we are honored to contribute to the Canadian ecosystem, working together to advance nuclear medicine globally. Our Director, Business Development, Ghadeer Shubassi, had the privilege of sharing insights about AtomVie Global Radiopharma's (AtomVie's) journey, our upcoming 72,300 sq. ft. state-of-the-art facility, and our mission of transforming patients' lives with high-quality radiopharmaceuticals. We look forward to participating in more events like this to further collaboration and advance our shared goals.   #AtomVieGlobalRadiopharma #NuclearMedicine #CanadianInnovation #TransformingLives #Webinar

We're #hiring a new Logistics and Materials Coordinator in Hamilton, Ontario. Apply today or share this post with your network.

We're #hiring a new Logistics and Materials Coordinator in Hamilton, Ontario. Apply today or share this post with your network.